Progyny, Inc.
For the period ended Aug 6, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 6, 2026 · Filed Aug 6, 2026
PGNY$34.84+1.4%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Adjusted EBITDA Calculation
Adjusted EBITDA Calculation
The following table provides a reconciliation of net income to Adjusted EBITDA for each of the periods presented:
| Three months ended · Six Months Ended | ||||
|---|---|---|---|---|
| June 30, | June 30, | |||
| 2026 | 2025 | 2026 | 2025 | |
| Net income | $28,052 | $17,112 | $52,284 | $32,171 |
| Add: | ||||
| Depreciation and amortization | 1,623 | 1,205 | 3,106 | 2,313 |
| Stock‑based compensation expense | 20,478 | 32,383 | 40,199 | 64,895 |
| Interest and other income, net | (1,134) | (2,719) | (2,638) | (5,086) |
| Provision for income taxes | 13,085 | 9,965 | 25,736 | 21,443 |
| Adjusted EBITDA | $62,104 | $57,946 | $118,687 | $115,736 |
| Revenue | $350,511 | $332,874 | $679,015 | $656,912 |
Reconciliation of Non-GAAP Financial Guidance for the Three Months Ending September 30, 2026 and Year Ending December 31, 2026
| Three Months Ending September 30, 2026 | Year Ending December 31, 2026 | |||
|---|---|---|---|---|
| Low | High | Low | High | |
| Revenue | $335,000 | $345,000 | $1,360,000 | $1,385,000 |
| Net Income | $24,500 | $26,700 | $104,800 | $109,900 |
| Add: | ||||
| Depreciation and amortization | 2,300 | 2,300 | 8,800 | 8,800 |
| Stock-based compensation expense | 21,500 | 21,500 | 80,000 | 80,000 |
| Interest and other income, net | (2,000) | (2,000) | (7,000) | (7,000) |
| Provision for income taxes | 9,700 | 10,500 | 46,400 | 48,300 |
| Adjusted EBITDA* | $56,000 | $59,000 | $233,000 | $240,000 |
| Three Months Ending September 30, 2026 | Year Ending December 31, 2026 | |||
|---|---|---|---|---|
| Low | High | Low | High | |
| Net Income | $24,500 | $26,700 | $104,800 | $109,900 |
| Add: | ||||
| Stock-based compensation | 21,500 | 21,500 | 80,000 | 80,000 |
| Income tax effect of non-GAAP adjustment | (5,400) | (5,400) | (15,200) | (15,200) |
| Adjusted Net income* | $40,600 | $42,800 | $169,600 | $174,700 |
| Diluted Shares | 82,000,000 | 82,000,000 | 83,000,000 | 83,000,000 |
| Adjusted Earnings Per Diluted Share | $0.50 | $0.52 | $2.04 | $2.10 |
- All of the numbers in the tables above reflect our future outlook as of the date hereof. Net income, Adjusted Net Income and Adjusted EBITDA ranges do not reflect any estimate for other potential activities and transactions, nor do they contemplate any discrete income tax items, including the income tax impact related to equity compensation activity.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.